News
Other risk factors for osteonecrosis of the jaw should be minimized — quitting smoking, reduction of glucocorticoids, replacement of poorly fitting dentures.
Until recently, osteonecrosis of the jaw had appeared in medical literature as no more than a curiosity, with little information on its cause or prevalence. With the initiation of widespread use ...
However, the risk of ONJ for osteoporosis patients taking these types of drugs is very low - much lower than the risk of breaking a bone. Most of the people who have gotten ONJ while taking ...
Researchers at the Columbia University College of Dental Medicine have identified a genetic variation that raises the risk of developing osteonecrosis of the jaw (ONJ) in patients who take ...
A patient receiving antiresorptive therapy for the prevention and treatment of osteoporosis has a low risk of developing osteonecrosis of the jaw (ONJ), and benefits of the medication outweigh the ...
Osteonecrosis of the jaw is caused by gum disease or improper healing. When gum doesn't cover bone, it can die. Treatment includes medications and surgery.
who recommends seeing a specialist, like an oral surgeon, if you develop this symptom. To reduce your risk of ONJ, Dr. Kearns recommends practicing good oral hygiene: Brush your teeth twice daily, ...
February 24, 2011— More details about osteonecrosis of the jaw (ONJ) associated with bisphosphonate use have been reported in 2 new studies published online February 11 in the Journal of Dental ...
Of the 212 patients with dental implants, only one developed ONJ, and she continued denosumab, healed her ONJ, and still has the implant," Watts explained in a press release.
Clinicians should be aware of near-fivefold raised risk for osteonecrosis of the jaw (ONJ) if zoledronic acid is used to prevent cancer bone metastases, warn researchers.
In addition, the minimal risk of ONJ is far outweighed by the high risk of the fragility fractures these medications prevent. And because people who do not take antiresorptive drugs can also ...
ONJ occurred in seven patients, six in group A and one in group B (P=0.049). The risk of ONJ was eight-fold lower with the reduced schedule than with the standard schedule.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results